MONDAY, Dec. 29 (HealthDay News) -- The cancer drug bortezomib (Velcade) may also be effective at treating and reversing the rejection of transplanted kidneys, a new study finds.

Bortezomib, which is used to treat cancer of the plasma cells, seems to target antibody-producing plasma cells that can cause organ rejection, according to the study, published in the Dec. 27 issue of the journal Transplantation.

"It has become clear that plasma cells and the antibo

MONDAY, Dec. 29 (HealthDay News) -- A diet rich in the inorganic phosphates found in many natural and processed foods accelerated the growth of lung cancers in rats, South Korean researchers report.

"Our study suggests that dietary regulation of inorganic phosphates may be critical for lung cancer treatment as well as prevention," Myung-Haing Cho, lead author of a report in the first January issue of American Journal of Re

MONDAY, Dec. 29 (HealthDay News) -- A new pamphlet has been published to help Spanish-speaking patients understand what to expect and watch for while taking the blood thinner warfarin.

Millions of Americans take warfarin, available under the brand name Coumadin, because they have an irregular heartbeat (known as atrial fibrillation), they've had a heart attack, or they are trying to prevent or treat blood clots in the legs or lungs.

But warfarin is the second

MONDAY, Dec. 29 (HealthDay News) -- Gay young adults whose families rejected them when they were younger are more likely to have histories of unprotected sex, illegal drug use and suicide attempts, new research suggests.

The findings don't prove that a family's negative

MONDAY, Dec. 29 (HealthDay News) -- An antifungal drug may offer hope for severe asthma patients who also suffer from a sensitivity to certain fungi, a new British study says.

A twice-daily dose of itraconazole improved runny nose, morning lung function and the quality of life of 62% of people with severe asthma and allergic sensitivity to at least one